Back to 
TUDOR INVESTMENT CORP ET AL
TUDOR INVESTMENT CORP ET AL
BRNSShowing 0 of 5 quarters
Position history for TUDOR INVESTMENT CORP ET AL's holdings in BARINTHUS BIOTHERAPEUTICS PL
No. Tudor Investment exited its BRNS (Barinthus Biotherapeutics PL) position in Q3 2022. Its Q2 2022 13F listed 266,927 shares worth $1.2M. Tudor Investment first reported BRNS in Q2 2021 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BRNS: Alphabet Inc., M&G Plc